au.\*:("LEONARDI, Antonio")
Results 1 to 7 of 7
Selection :
NF-κB in solid tumorsPACIFICO, Francesco; LEONARDI, Antonio.Biochemical pharmacology. 2006, Vol 72, Num 9, pp 1142-1152, issn 0006-2952, 11 p.Article
NGAL Controls the Metastatic Potential of Anaplastic Thyroid Carcinoma CellsVOLPE, Vincenzo; RAIA, Zelinda; SANGUIGNO, Luca et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 1, pp 228-235, issn 0021-972X, 8 p.Article
The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells Another piece in the adipokines puzzleCIRILLO, Plinio; DI PALMA, Vito; MARESCA, Fabio et al.Thrombosis research. 2012, Vol 130, Num 3, pp 403-408, issn 0049-3848, 6 p.Article
RbAp48 is a target of nuclear factor-κB activity in thyroid cancerPACIFICO, Francesco; PAOLILLO, Michele; LEONARDI, Antonio et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 4, pp 1458-1466, issn 0021-972X, 9 p.Article
Nuclear Factor-κB Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146aPACIFICO, Francesco; CRESCENZI, Elvira; MELLONE, Stefano et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 3, pp 1421-1430, issn 0021-972X, 10 p.Article
Novel Toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitorsDAMIANO, Vincenzo; CAPUTO, Rosa; BIANCO, Roberto et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 577-583, issn 1078-0432, 7 p.Article
NF-κB activating scaffold proteins as signaling molecules and putative therapeutic targetsCHARIOT, Alain; MEUWIS, Marie-Alice; BONIF, Marianne et al.Current medicinal chemistry. 2003, Vol 10, Num 7, pp 593-602, issn 0929-8673, 10 p.Article